These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Warfarin prophylaxis in the antiphospholipid antibody syndrome. Gelber AC; Saleh AS N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14699652 [No Abstract] [Full Text] [Related]
46. Warfarin prophylaxis in the antiphospholipid antibody syndrome. Kosinski CM N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14699651 [No Abstract] [Full Text] [Related]
47. The effectiveness of warfarin dosing from a nomogram compared with house staff dosing. Asnis PD; Gardner MJ; Ranawat A; Leitzes AH; Peterson MG; Bass AR J Arthroplasty; 2007 Feb; 22(2):213-8. PubMed ID: 17275636 [TBL] [Abstract][Full Text] [Related]
48. Guidelines on oral anticoagulation with warfarin - fourth edition. Keeling D; Baglin T; Tait C; Watson H; Perry D; Baglin C; Kitchen S; Makris M; Br J Haematol; 2011 Aug; 154(3):311-24. PubMed ID: 21671894 [No Abstract] [Full Text] [Related]
49. The economics of anticoagulation: what are the issues? Am J Manag Care; 2004 Oct; 10(10 Suppl):S292-6. PubMed ID: 15605699 [No Abstract] [Full Text] [Related]
51. Low intensity warfarin: is it clinically useful in venous thromboembolism management? Bauer KA Br J Haematol; 2004 Oct; 127(2):155-8. PubMed ID: 15461620 [TBL] [Abstract][Full Text] [Related]
52. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study. Ruud E; Holmstrøm H; De Lange C; Hogstad EM; Wesenberg F Acta Paediatr; 2006 Sep; 95(9):1053-9. PubMed ID: 16938749 [TBL] [Abstract][Full Text] [Related]
53. Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol. Beksaç B; González Della Valle A; Anderson J; Sharrock NE; Sculco TP; Salvato EA Clin Orthop Relat Res; 2007 Oct; 463():114-9. PubMed ID: 17960674 [TBL] [Abstract][Full Text] [Related]
54. Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism. Motsch J; Walther A; Bock M; Böttiger BW Curr Opin Anaesthesiol; 2006 Feb; 19(1):52-8. PubMed ID: 16547433 [TBL] [Abstract][Full Text] [Related]
55. Duration of anticoagulation after first episode of unprovoked venous thromboembolism. Abdel-Razeq HN; Radwi GR Saudi Med J; 2004 Nov; 25(11):1776; author reply 1776-7. PubMed ID: 15573235 [No Abstract] [Full Text] [Related]
56. Prevention of venous thromboembolism among hospitalized medical patients. Goldhaber SZ; Turpie AG Circulation; 2005 Jan; 111(1):e1-3. PubMed ID: 15630031 [No Abstract] [Full Text] [Related]
57. Long term, low intensity warfarin helps against deep vein thrombosis. Gottlieb S BMJ; 2003 Mar; 326(7388):516. PubMed ID: 12623891 [No Abstract] [Full Text] [Related]
58. [Prevention of venous thrombosis and pulmonary embolism. Scoring system of the risk of TEN development]. Pacejka M; Adamíková A Vnitr Lek; 1999 May; 45(5):273-6. PubMed ID: 15641248 [TBL] [Abstract][Full Text] [Related]
59. [Deep venous thrombosis and pulmonary embolism. Prophylaxis and therapy]. Beyer J; Schellong S Herz; 2005 May; 30(3):204-11. PubMed ID: 15902371 [TBL] [Abstract][Full Text] [Related]